Skip to content
karyopharm-logo
Logo for Karyopharm
Main Menu
Contact
Clinical Trials
Careers
Follow Us
LinkedIn
Twitter
Search
About
Show submenu
About Karyopharm
Management Team
Board of Directors
Scientific Advisory Board
Careers
Science
Show submenu
SINE Technology (Selective Inhibitor of Nuclear Export)
Pipeline
Our Medicines
Patients
Show submenu
Overview
SINE Technology
Multiple Myeloma
Diffuse Large B-Cell Lymphoma (DLBCL)
Clinical Trials
Patient Resources
Responsibility
Show submenu
Supporting Medical Research
Expanded Access
Grants & Giving
Corporate Sustainability
Investors & Media
Show submenu
Corporate Profile
Press Releases
Media Assets
Events & Presentations
Corporate Governance
Show submenu
Management Team
Board of Directors
Committee Composition
Contact the Board
Financial Information
Show submenu
SEC Filings
Annual Reports & Proxy Statements
Analyst Coverage
Investor FAQs
Publications and Presentations
Corporate Sustainability
Contact Us
Show submenu
Investor Alerts
Press Releases
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Investor Alerts
Year
All Years
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Asset Types
Photos
Video
Audio
Documents
Events
Standard
Show
5
10
25
50
100
per page
«
1
…
51
52
53
54
55
56
57
58
59
»
Click here to print this page.
Click here to send us an email.
Click here to subscribe to RSS Feed.
Agree to Our Terms of Use
I Agree
*
I agree to the storing and processing of my personal data by Karyopharm as described in the
Privacy Policy
and to the
Terms of Use
. I agree to receive communications from Karyopharm and understand that I can unsubscribe at any time.
